CADENCE: A Snapshot of Angina in Primary Care Practice

Although the options for treating angina — both pharmacological and mechanical — have evolved considerably, the literature on contemporary patterns of angina prevalence and control in outpatients with coronary artery disease remains remarkably sparse. The Coronary Artery Disease in General Practice (CADENCE) study, conducted collaboratively with the manufacturer of the antianginal drug ivabradine, included 2031 consecutive patients with a diagnosis of stable angina (mean age, 71; men, 63%; history of MI, 47%) cared for by 207 primary care practitioners in Australia. The patients completed the Seattle Angina Questionnaire, a validated instrument for quantifying angina characteristics. Only 53% were taking beta-blockers, and 39% were taking l…